Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akili, Inc. stock logo
AKLI
Akili
$0.43
$0.43
$0.19
▼
$1.25
$34.01M1.722.20 million shsN/A
CVRx, Inc. stock logo
CVRX
CVRx
$5.52
+0.4%		$5.27
$4.37
▼
$11.30
$146.50M0.81321,335 shs23,259 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.70
+3.4%		$0.78
$0.38
▼
$2.45
$111.06M2.323.44 million shs320,016 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.79
+4.8%		$0.95
$0.66
▼
$7.44
$142.72M1.941.78 million shs242,248 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akili, Inc. stock logo
AKLI
Akili
0.00%0.00%0.00%0.00%0.00%
CVRx, Inc. stock logo
CVRX
CVRx
+6.18%+12.70%-1.79%-26.67%-27.25%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-1.14%-15.46%-11.13%-2.41%-62.59%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
+5.51%+1.52%-22.84%-18.41%+74,899,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akili, Inc. stock logo
AKLI
Akili
$0.43
$0.43
$0.19
▼
$1.25
$34.01M1.722.20 million shsN/A
CVRx, Inc. stock logo
CVRX
CVRx
$5.52
+0.4%		$5.27
$4.37
▼
$11.30
$146.50M0.81321,335 shs23,259 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.70
+3.4%		$0.78
$0.38
▼
$2.45
$111.06M2.323.44 million shs320,016 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.79
+4.8%		$0.95
$0.66
▼
$7.44
$142.72M1.941.78 million shs242,248 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akili, Inc. stock logo
AKLI
Akili
0.00%0.00%0.00%0.00%0.00%
CVRx, Inc. stock logo
CVRX
CVRx
+6.18%+12.70%-1.79%-26.67%-27.25%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-1.14%-15.46%-11.13%-2.41%-62.59%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
+5.51%+1.52%-22.84%-18.41%+74,899,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akili, Inc. stock logo
AKLI
Akili
0.00
N/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
2.67
Moderate Buy$11.50108.33% Upside
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.50
Moderate Buy$5.12631.43% Upside
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
2.00
Hold$8.00919.11% Upside

Current Analyst Ratings Breakdown

Latest AKLI, STEX, CVRX, and GUTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/29/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/6/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/4/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$8.00
5/21/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$9.00 ➝ $8.00
5/12/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
5/6/2026
CVRx, Inc. stock logo
CVRX
CVRx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akili, Inc. stock logo
AKLI
Akili
$1.95M17.46N/AN/A$0.75 per share0.58
CVRx, Inc. stock logo
CVRX
CVRx
$56.65M2.59N/AN/A$1.50 per share3.68
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K1,233.94N/AN/A$0.07 per share10.00
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/AN/AN/AN/A$0.83 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akili, Inc. stock logo
AKLI
Akili
-$59.49M-$0.61N/AN/AN/A-2,492.04%-79.93%-59.16%N/A
CVRx, Inc. stock logo
CVRX
CVRx
-$53.31M-$2.02N/AN/AN/A-89.14%-120.76%-48.38%8/6/2026 (Estimated)
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/A

Latest AKLI, STEX, CVRX, and GUTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.15N/AN/AN/AN/AN/A
8/6/2026Q2 2026
CVRx, Inc. stock logo
CVRX
CVRx
-$0.52N/AN/AN/A$15.55 millionN/A
5/14/2026Q1 2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$0.27N/A-$0.27N/AN/A
5/12/2026Q1 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.17$0.06+$0.23$0.06N/AN/A
5/11/2026Q1 2026
CVRx, Inc. stock logo
CVRX
CVRx
-$0.51-$0.50+$0.01-$0.50$14.49 million$14.77 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Akili, Inc. stock logo
AKLI
Akili
N/AN/AN/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akili, Inc. stock logo
AKLI
Akili
0.08
5.80
5.80
CVRx, Inc. stock logo
CVRX
CVRx
2.01
10.20
8.89
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.41
4.28
4.28
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A
13.90
13.90

Institutional Ownership

CompanyInstitutional Ownership
Akili, Inc. stock logo
AKLI
Akili
53.12%
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
7.16%

Insider Ownership

CompanyInsider Ownership
Akili, Inc. stock logo
AKLI
Akili
10.10%
CVRx, Inc. stock logo
CVRX
CVRx
16.60%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8.52%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
52.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akili, Inc. stock logo
AKLI
Akili
13078.73 million70.78 millionNo Data
CVRx, Inc. stock logo
CVRX
CVRx
16026.54 million22.13 millionOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
102158.65 million145.13 millionN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
50181.81 million85.94 millionN/A

Recent News About These Companies

Critical Analysis: Biosig Technologies (NASDAQ:STEX) & Conexeu Sciences (NASDAQ:CNXU)
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931627
Streamex Corp. Details GLDY's Liquidity Infrastructure; ~$12 Million in Seeded Liquidity Supports 24/7, 365 Instant Trading Across Multiple Institutional-Grade Venues
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332040/22558/en/streamex-corp-details-gldy-s-liquidity-infrastructure-12-million-in-seeded-liquidity-supports-24-7-365-instant-trading-across-multiple-institutional-grade-venues.html
Streamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with Wintermute
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332019/22558/en/streamex-corp-announces-24-7-365-instant-liquidity-for-gldy-through-collaboration-with-wintermute.html
Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330340/22558/en/streamex-corp-announces-gldy-now-available-for-custody-by-inspira-financial-unlocking-yield-bearing-gold-exposure-for-traditional-finance-investors.html
Wall Street Zen Downgrades Biosig Technologies (NASDAQ:STEX) to Strong Sell
July 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-biosig-technologies-nasdaqstex-to-strong-sell-2026-07-18/
Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY
July 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/17/3329036/22558/en/streamex-corp-announces-june-2026-yield-dividend-distribution-for-gldy.html
Streamex GLDY Clears Key Trust Milestone With First Independent Gold Reserve Attestation
July 8, 2026  |  thenewswire.comT
Streamex Corp. Announces 10,000,000 Share Repurchase Program
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323059/22558/en/streamex-corp-announces-10-000-000-share-repurchase-program.html
Streamex Yield-Bearing Gold Asset GLDY Just Went Mainstream
July 2, 2026  |  thenewswire.comT
Streamex Corp. Announces First Independent Reserve Attestation by EisnerAmper for GLDY
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320524/22558/en/streamex-corp-announces-first-independent-reserve-attestation-by-eisneramper-for-gldy.html
Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3318871/22558/en/streamex-corp-brings-yield-bearing-gold-gldy-to-traditional-brokerage-accounts-through-collaboration-with-siebert-financial-and-tzero.html
Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315196/22558/en/streamex-corp-announces-may-2026-yield-dividend-distribution-for-gldy.html
Biosig Technologies (NASDAQ:STEX) Chairman Morgan Lee Lekstrom Purchases 50,000 Shares
June 16, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stex-insider-buying-and-selling-2026-06-16/
Biosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 23,810 Shares
June 3, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stex-insider-buying-and-selling-2026-06-03/
[Video Enhanced] Streamex has Created a Compliant Secondary Market for Real World Assets
June 2, 2026  |  thenewswire.comT
Insider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Buys 34,000 Shares of Stock
May 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stex-insider-buying-and-selling-2026-05-29/
[Video Enhanced] Streamex Adds Microsoft and PayPal Lead Product Designer to High-Level Talent Roster
May 28, 2026  |  thenewswire.comT
Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset
May 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/27/3301822/22558/en/streamex-corp-and-orca-announce-launch-of-24-7-decentralized-secondary-liquidity-infrastructure-for-tokenized-securities-gldy-the-inaugural-asset.html
Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3300976/22558/en/streamex-corp-appoints-former-microsoft-and-paypal-lead-product-designer-kori-handy-as-vice-president-of-product-and-design.html
Insider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Purchases 147,000 Shares of Stock
May 22, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stex-insider-buying-and-selling-2026-05-22/
Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates
May 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/21/3299210/22558/en/streamex-corp-provides-q1-2026-earnings-and-corporate-update-presentation-recap-highlights-new-partnerships-key-updates.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akili stock logo

Akili NASDAQ:AKLI

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.

CVRx stock logo

CVRx NASDAQ:CVRX

$5.52 +0.02 (+0.36%)
As of 12:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$0.70 +0.02 (+3.37%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Biosig Technologies stock logo

Biosig Technologies NASDAQ:STEX

$0.78 +0.04 (+4.81%)
As of 12:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas